| 24.23 0.03 (0.12%) | 04-24 15:47 | |||||||||||||
|
|
| Short term | |
|||
| Mid term | |
|||
| Targets | 6-month : | 1-year : | ||
| Resists | First : | Second : | ||
| Pivot price | ||||
| Supports | First : | Second : | ||
| MAs | MA(5) : | MA(20) : | ||
| MA(100) : | MA(250) : | |||
| MACD | MACD : | Signal : | ||
| %K %D | K(14,3) : | D(3) : | ||
| RSI | RSI(14): | |||
| 52-week | High : | Low : | ||
| If tomorrow: | Open lower | Open higher |
| High: | - | - |
| Low: | - | - |
| Close: | - | - |
IntriCon Corporation is a global company engaged in the creation, engineering, manufacturing, and distribution of various body-worn technologies. Its operations span the United States, Europe, Asia, and other international regions. The company develops a sophisticated array of products, including micro-miniature devices, advanced microelectronics, precision micro-mechanical assemblies, high-quality injection-molded plastic parts, and integrated software solutions. These offerings primarily serve the medical device, hearing healthcare, and professional audio communication industries. Within the medical sector, IntriCon provides specialized micro coils essential for surgical navigation in fields like interventional pulmonology and electrophysiology. It also offers comprehensive engineering and manufacturing support for intricate medical devices, including a wide range of catheters applied in cardiology, peripheral vascular, neurology, radiology, and pulmonology. Furthermore, the company supplies bubble sensors and flow restrictors crucial for monitoring and controlling fluid in intravenous infusion systems, alongside safety needle products for original equipment manufacturers. For professional audio markets, IntriCon produces robust headset products tailored for emergency response teams in fire, law enforcement, safety, aviation, and military contexts. It also manufactures a variety of miniature ear- and head-worn devices preferred by performers and support personnel in the music and stage performance industries. IntriCon utilizes diverse sales channels: hearing devices, medical, and professional audio communication products are sold directly to manufacturers, distributors, and through partnerships. Microphone products reach the radio communication and professional audio sectors. Additionally, the company directly markets and sells hearing aid devices to consumers through direct mail, online platforms, and call centers. Originally incorporated as Selas Corporation of America in 1930, the company is now known as IntriCon Corporation and is based in Arden Hills, Minnesota.
Thu, 23 Oct 2025
Three Weeks In, Intricon-Minnetronix Merger Takes Shape - Medical Device and Diagnostic industry
Wed, 08 Oct 2025
Intricon and Minnetronix merge to form Forj Medical - Medical Design & Outsourcing
Wed, 08 Oct 2025
Intricon, Minnetronix Medical merge to form Forj Medical - The Business Journals
Thu, 12 Jun 2025
Intricon Corp invests $30M in automation, plans to boost robotics team - The Business Journals
Mon, 03 Feb 2025
Intricon expands in Minnesota in response to recent growth - Medical Design & Outsourcing
Thu, 23 Jan 2025
Intricon expands headquarters in Arden Hills to boost production capacity - The Business Journals
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Outperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Instruments & Supplies
|
|
| Shares Out | 0 (M) |
| Shares Float | 0 (M) |
| Held by Insiders | (%) |
| Held by Institutions | (%) |
| Shares Short | 0 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | |
| EPS Est Next Qtrly | |
| EPS Est This Year | |
| EPS Est Next Year | |
| Book Value (p.s.) | |
| Profit Margin | % |
| Operating Margin | % |
| Return on Assets (ttm) | % |
| Return on Equity (ttm) | % |
| Qtrly Rev. Growth | % |
| Gross Profit (p.s.) | |
| Sales Per Share | |
| EBITDA (p.s.) | |
| Qtrly Earnings Growth | % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | |
| PEG Ratio | |
| Price to Book value | |
| Price to Sales | |
| Price to Cash Flow |
| Dividend | |
| Forward Dividend | |
| Dividend Yield | 0% |
| Dividend Pay Date | |
| Ex-Dividend Date |